Ortho Clinical Diagnostics to Present Data on Automation in Immunohematology and Demonstrate Its Entire Transfusion Medicine Portfolio at the 2017 AABB Annual Meeting

RARITAN, N.J., Oct. 2, 2017 /PRNewswire/ -- Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, today announced it will present new scientific research on automation in immunohematology, or pre-transfusion compatibility testing, at the 2017 AABB Annual Meeting. For the first time at AABB, the company will showcase its entire transfusion medicine portfolio in its booth (No. 1635). Ortho will also host an industry workshop regarding standardization of the titration process and a customer event focused on emergency preparedness and military readiness featuring keynote speeches by leaders representing the Military's Armed Services Blood Program. The conference will be held October 7-10 at the San Diego Convention Center.

"With blood banks facing constant cost and resource pressures, simplicity and standardization is the key to success. Ortho's best-in-class instrumentation, assay menu and digital solutions help transfusion professionals deliver accurate results safely and effectively to truly elevate critical patient care," said Heidi Casaletto, head of transfusion medicine for Ortho.

Ortho and its customers will share the following poster presentations:

• ORTHO VISION^® Automated Analyzers Enable Efficient and Reproducible Measurement of Prenatal Antibody Titers Though Clinical Correlation Studies Are Necessary for Clinical Implementation (CP299)
• Author Presentations: October 7 at 7:30 a.m. ? 8:00 p.m.; October 8 & 9 at 7:30 a.m. ? 6:00 p.m.; and October 10 at 7:30 a.m. ? 2:00 p.m.
• Presenters: Dr. Brian Adkins, Princess Maynie, Carol Chandler, Shelia Garret and Pampee Young, Vanderbilt University Medical Center, Department of Pathology, Microbiology and Immunology, Nashville, TN

• Evaluation of the Impact of Advancements of New Automation on Future Challenges (AP32)
• Author Presentations: October 7 at 7:30 a.m. ? 8:00 p.m.; October 8 & 9 at 7:30 a.m. ? 6:00 p.m.; and October 10 at 7:30 a.m. ? 2:00 p.m.
• Presenter: Tony S. Casina, Ortho Clinical Diagnostics

• Impact Study of a New Automation System on Transfusion Medicine Operations (AP97)
• Author Presentations: October 7 at 7:30 a.m. ? 8:00 p.m.; October 8 & 9 at 7:30 a.m. ? 6:00 p.m.; and October 10 at 7:30 a.m. ? 2:00 p.m.
• Presenter: Tony S. Casina, Ortho Clinical Diagnostics

The company will conduct an industry workshop on Monday, October 9 at 7:00 a.m., entitled, "Standardization and Validation of Titrations in Perinatal Clinical Situations". Speakers at this workshop will address clinical outcomes associated with performing titration studies using the ID-MTStm Gel Test method, process improvements that can be realized through standardization of the titration process, and best practices for successful process implementation in the transfusion service laboratory. Presenters include Laura L.W. Cooling, MD, MS, Associate Professor and Associate Director, Blood Bank and Transfusion Medicine Director, Cell Therapy Laboratory, Department of Pathology at the University of Michigan Medical School; Robert Witkowski, PhD, Principal Scientist, Research and Development at Ortho Clinical Diagnostics; and Christina Gendron, MLS (ASCP), Senior Medical Technologist, Transfusion Service at Florida Hospital.

Ortho will demonstrate its fully automated transfusion medicine solution, featuring ORTHO VISION^® and ORTHO VISION^® Max analyzers that improve workflow and standardize systems and processes in transfusion laboratories. The solution's full menu automation offers the most diverse testing capabilities on the market today, including complex testing and extended phenotyping with ORTHOtm Sera[1]. Connecting the ORTHO VISION^® Platform is the ORTHO CONNECTtm V2.0[2] middleware solution, which centralizes management across multiple instruments and laboratories to create a seamless flow of information, allowing lab professionals to manage workload from a single console.

Ortho will also host an exclusive invitation-only customer event, "Emergency Preparedness and Military Readiness: Are They the Same? A symposium on the lessons learned through the implementation of Low Titer Group O Whole Blood (LTOWB) in trauma management." Colonel Audra Taylor, director, and Lieutenant Colonel Jason Corley, deputy director, of the Army Blood Program will discuss how the military's implementation of LTOWB might apply to civilian hospitals' disaster response.

About Ortho Clinical Diagnostics

Ortho Clinical Diagnostics is a global leader of in vitro diagnostics serving the global clinical laboratory and immunohematology communities. Across hospitals, hospital networks, blood banks, and labs in more than 100 countries, Ortho's high-quality products and services enable health care professionals to make better-informed treatment decisions. Ortho brings sophisticated testing technologies, automation, and information management and interpretation tools to clinical laboratories around the world to help them run more efficiently and effectively and improve patient care. For the immunohematology community, Ortho's blood typing products help ensure every patient receives blood that is safe, the right type and the right unit. Ortho's purpose is to improve and save lives with diagnostics, and it does that by reimagining what's possible. This is what has defined Ortho for more than 75 years, and it's what drives Ortho forward. For more information, visit www.orthoclinicaldiagnostics.com.

© Ortho Clinical Diagnostics 2017

PR-03300

[1] ORTHOtm Sera for use with the ORTHO VISION® Platform is commercially available in CE marked countries.  ORTHO Sera is pending FDA clearance for use with the ORTHO VISION Platform.  

[2] ORTHO CONNECTtm is commercially available in CE marked countries and is pending FDA clearance.

SOURCE Ortho Clinical Diagnostics